Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Therma Bright Inc > Confirming news
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1179)
•••
Comment by Moemoney42on Apr 13, 2021 4:40pm
142 Views
Post# 32987208

RE:RE:RE:RE:RE:Confirming news

RE:RE:RE:RE:RE:Confirming news
forrest6748 wrote: They did test  the variant as they can't figure who has it and who has not the variant. The result was probably lower with the variant. This is why

Therma Bright and its R&D team are now initiating an additional second phase study to optimize AcuVid™, in collaboration with Safetest Diagnsticos and University of Minas Gerais, to substantiate AcuVid™ test's ability to detect known variants that are currently circulating worldwide.

Isn't it funny that once again, this PR brings forth new hurdles that should have been expressed when they first said they were going to test in Brazil.. what is this now 6-7 times that they bring another excuse to the table for a delay.. something they should have mentioned right off the hop..  they knew there were other variants for how long now..?? I've known about them for months.. (and I'm not developing a covid test!) even before the Dec. PR that said this would all be done by Mid Jan. 2021 if it wasn't for Xmas holidays.. LOL.. And you wonder why the stock sells off..???
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities